This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
Molecular Neurodegeneration Open Access 03 June 2022
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Cignarella, F. et al. TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis. Acta Neuropathol. https://doi.org/10.1007/s00401-020-02193-z (2020)
Related article
Ulland, T. K. & Colonna, M. TREM2 — a key player in microglial biology and Alzheimer disease. Nat. Rev. Neurol. 14, 667–675 (2018)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wood, H. TREM2 activation promotes remyelination. Nat Rev Neurol 16, 522 (2020). https://doi.org/10.1038/s41582-020-0404-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-0404-9
This article is cited by
-
The evolution of the global COVID-19 epidemic in Morocco and understanding the different therapeutic approaches of chitosan in the control of the pandemic
Polymer Bulletin (2023)
-
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
Molecular Neurodegeneration (2022)